Amanote Research
Register
Sign In
SLIT2 Promoter Methylation Analysis in Neuroblastoma, Wilms' Tumour and Renal Cell Carcinoma
British Journal of Cancer
- United Kingdom
doi 10.1038/sj.bjc.6601447
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
January 1, 2004
Authors
D Astuti
N F da Silva
A Dallol
D Gentle
T Martinsson
P Kogner
R Grundy
T Kishida
M Yao
F Latif
E R Maher
Publisher
Springer Science and Business Media LLC
Related search
Wilms' Tumour 1 Can Suppress hTERT Gene Expression and Telomerase Activity in Clear Cell Renal Cell Carcinoma via Multiple Pathways
British Journal of Cancer
Cancer Research
Oncology
RASSF1A Promoter Methylation Correlates Development, Progression, and Poor Cancer-Specific Survival of Renal Cell Carcinoma: Trial Sequential Analysis
OncoTargets and Therapy
Oncology
Pharmacology
Methylation of STK11 Promoter Is a Risk Factor for Tumor Stage and Survival in Clear Cell Renal Cell Carcinoma
Oncology Letters
Cancer Research
Oncology
Epigenetic Alteration at the DLK1-GTL2 Imprinted Domain in Human Neoplasia: Analysis of Neuroblastoma, Phaeochromocytoma and Wilms' Tumour
British Journal of Cancer
Cancer Research
Oncology
DNA Methylation Profiling Reveals Novel Diagnostic Biomarkers in Renal Cell Carcinoma
BMC Medicine
Medicine
Age-Related Properties of the Tumour Vasculature in Renal Cell Carcinoma
BJU International
Urology
APC Promoter Methylation and Protein Expression in Hepatocellular Carcinoma
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
Promoter Methylation-Associated Silencing of P27kip1 Gene With Metastasis in Esophageal Squamous Cell Carcinoma
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Aberrant GRK6 Promoter Methylation Is Associated With Poor Prognosis in Hypopharyngeal Squamous Cell Carcinoma
Oncology Reports
Medicine
Cancer Research
Oncology